Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i

Euglycemic diabetic ketoacidosis (euglycemic DKA) is a serious complication of diabetes, which can occur in some patients treated with oral antidiabetics called sodium-glucose co-transporter 2 inhibitors (SGLT2i). This group of drugs works by increasing renal excretion of sodium and glucose, thereby...

Descripción completa

Detalles Bibliográficos
Autores principales: Velasco de Cos, Guillermo, Sánchez-Molina Acosta, María Isabel, Fernández, María Matilde Toval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Communications and Publications Division (CPD) of the IFCC 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941065/
https://www.ncbi.nlm.nih.gov/pubmed/33753980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941065/
https://www.ncbi.nlm.nih.gov/pubmed/33753980

Ejemplares similares